Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial

Detalles Bibliográficos
Autores principales: Hagel, Stefan, Bach, Friedhelm, Brenner, Thorsten, Bracht, Hendrik, Brinkmann, Alexander, Annecke, Thorsten, Hohn, Andreas, Weigand, Markus Alexander, Michels, Guido, Kluge, Stefan, Nierhaus, Axel, Jarczak, Dominik, König, Christina, Weismann, Dirk, Frey, Otto, Witzke, Dominic, Müller, Carsten, Bauer, Michael, Kiehntopf, Michael, Neugebauer, Sophie, Lehmann, Thomas, Roberts, Jason A., Pletz, Mathias W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050772/
https://www.ncbi.nlm.nih.gov/pubmed/35303118
http://dx.doi.org/10.1007/s00134-022-06668-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050772/
https://www.ncbi.nlm.nih.gov/pubmed/35303118
http://dx.doi.org/10.1007/s00134-022-06668-3

Ejemplares similares